RHOA and osteoporosis: Sema4D-/- mice demonstrate a mild osteosclerotic phenotype, identical to Plexin-B1−/− mice and mice expressing dominant-negative RhoA, so this signaling pathway could have therapeutic implications in diseases such as osteoporosis.